Repository logo

Browsing by Issue Date, starting with "2023-08-17"

Filter results by year or month
Now showing 1 - 2 of 2
  • Emotional Intelligence Outcomes in Higher Education Institutions: Empirical Evidence From a Western Context
    Publication . Soliman, Mohammad; Sinha, Rupa; Di Virgilio, Francesca; Sousa, Maria Jose; Figueiredo, Ronnie
    The main outcomes of emotional intelligence (EMI) in the workplace have been researched in a variety of settings, however, few studies have focused on such consequences, particularly in the context of higher education institutions (HEIs). This research is therefore to empirically examine the impact of EMI on work-life balance, job insecurity, knowledge sharing behaviour, and workforce agility at HEIs. A total of 368 responses from academic staff members in Italy were analysed using PLS-SEM. The findings indicated that EMI has a significant impact on workforce agility, work-life balance, job insecurity, and knowledge sharing behaviour. In addition, work-life balance significantly impacted knowledge sharing behaviour, which in turn affected workforce agility. This article adds to the body of knowledge on the human resources management domain by highlighting the key consequences of EMI in HEIs within a western context. It also provides various managerial implications for concerned faculty members and senior managers at HEIs. Research limitations and avenues for further research are given.
    2023-08-17Journal article Restricted access Show more
  • The use of the CNIC-Polypill in real-life clinical practice: opportunities and challenges in patients at very high risk of atherosclerotic cardiovascular disease – expert panel meeting report
    Publication . Grigorian-Shamagian, Lilian; Coca, Antonio; Morais, Joao; Perez-Martinez, Pablo; Barragan, Adriana; Barrientos, Ana Isabel; e Silva, Alexandre Amaral; Sugraliyev, Akhmetzhan; Parkhomenko, Alexander; Liprandi, Álvaro Sosa; Parapid, Biljana; Olivares, Carlos; Negretti, Carlos Ignacio Ponte; Quesada, Daniel; Kosevic, Dragana; Gastelum, Edith Ruiz; López, Emilio Samael Peralta; Araujo, Francisco; Padilla Padilla, Francisco Gerardo; Krzesinski, François; Alhaddad, Imad; Fernandez, Jose Alejandro Chavez; Gonzalez-Juanatey, Jose R.; Arnaout, M. Samir; Castellanos, Mar; Mendez, Maxima; Acevedo, Monica; Koval, Olena; Jorge, Pablo; Zelveian, Parounak; Kreutz, Reinhold; Tseluyko, Vira
    Although the cardiovascular (CV) polypill concept is not new and several guidelines state that a CV polypill should be considered an integral part of a comprehensive CV disease (CVD) prevention strategy, there are still some barriers to its implementation in the real-world setting, mainly in secondary CV prevention. As the CNIC-polypill is the only one approved for secondary CV prevention in patients with atherosclerotic CVD in 27 countries worldwide, a panel of four discussants and 30 participants from 18 countries conveyed in a virtual meeting on April 21, 2022, to discuss key clinical questions regarding the practical use of the CNIC-Polypill and barriers to its implementation. Data presented showed that, although the use of the CV polypill is not explicitly mentioned in the current 2021 European Society of Cardiology guidelines on CVD prevention, it may be used in any patient for secondary CVD prevention tolerating all their components to improve outcomes through different aspects. The favourable results of the Secondary Prevention of Cardiovascular Disease in the Elderly (SECURE) trial now reinforce this recommendation. The panellists presented algorithms on how to switch from any baseline regimen when starting treatment with the CNIC-polypill in different situations, including patients with hypertension, dyslipidaemia, and a previous CV event; at discharge after a cardiovascular event; in chronic ischemic conditions; and in cases of polypharmacy. The panellists and expert discussants did agree that available studies conducted so far with the CNIC-polypill demonstrate that it is as efficacious as the monocomponents, equipotent drugs, or other therapies; reduces the risk of experiencing recurrent major CV events; improves medication adherence; reduces health care costs and resources compared to patients treated with loose drugs; and the patients prefer it over the multipill strategy. In conclusion, the data presented by the participants provided the evidence behind the use of the CNIC-polypill to help fulfil the goal of encouraging its adoption by physicians.
    2023-08-17Journal article Open access Show more